第一单位：
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
作者：
Rishika,Prasad [1]
;
Abdur,Rehman [2]
;
Lubna,Rehman [2]
;
Faezeh,Darbaniyan [2]
;
Viktoria,Blumenberg [3]
;
Maria-Luisa,Schubert [4]
;
Uria,Mor [5]
;
Eli,Zamir [6]
;
Sabine,Schmidt [6]
;
Tomo,Hayase [1]
;
Chia-Chi,Chang [1]
;
Lauren,McDaniel [1]
;
Ivonne,Flores [1]
;
Paolo,Strati [2]
;
Ranjit,Nair [2]
;
Dai,Chihara [2]
;
Luis E,Fayad [2]
;
Sairah,Ahmed [2]
;
Swaminathan P,Iyer [2]
;
Michael,Wang [2]
;
Preetesh,Jain [2]
;
Loretta J,Nastoupil [2]
;
Jason,Westin [2]
;
Reetakshi,Arora [2]
;
Joel,Turner [7]
;
Fareed,Khawaja [8]
;
Ranran,Wu [9]
;
Jennifer B,Dennison [9]
;
Meghan,Menges [7]
;
Melanie,Hidalgo-Vargas [7]
;
Kayla,Reid [7]
;
Marco L,Davila [10]
;
Peter,Dreger [4]
;
Felix,Korell [4]
;
Anita,Schmitt [4]
;
Mark R,Tanner [11]
;
Richard E,Champlin [11]
;
Christopher R,Flowers [2]
;
Elizabeth J,Shpall [11]
;
Samir,Hanash [9]
;
Sattva S,Neelapu [2]
;
Michael,Schmitt [4]
;
Marion,Subklewe [3]
;
Johannes,Francois-Fahrmann [9]
;
C K,Stein-Thoeringer [12]
;
Eran,Elinav [13]
;
Michael D,Jain [7]
;
Eiko,Hayase [1]
;
Robert R,Jenq [14]
;
Neeraj Y,Saini [15]
作者单位：
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
[1]
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
[2]
Department of Medicine III, Ludwig Maximilian University of Munich University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.;Laboratory for Translational Cancer Immunology, Ludwig Maximilian University of Munich Gene Center, Ludwig Maximilian University of Munich, Munich, Germany.;German Cancer Consortium and Bavarian Center for Cancer Research, Partner Site Munich, Munich, Germany.
[3]
Department of Hematology, Oncology, and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.
[4]
Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
[5]
Division of Microbiome and Cancer, German Cancer Consortium, Heidelberg, Germany.
[6]
Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
[7]
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.
[8]
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX.
[9]
Department of Stem Cell Transplantation and Cellular Therapy, Roswell Cancer Institute, Buffalo, NY.
[10]
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
[11]
Department of Internal Medicine I, University Clinic Tüebingen, Tüebingen, Germany.;M3 Research Institute, Faculty of Medicine, University of Tüebingen, Tüebingen, Germany.
[12]
Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.;Division of Microbiome and Cancer, German Cancer Consortium, Heidelberg, Germany.
[13]
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.;Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
[14]
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.;Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
[15]
DOI
10.1182/blood.2024025366
PMID
39441941
发布时间
2026-02-21
换一批
